Literature DB >> 7694266

Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP.

E G Langeler1, C J van Uffelen, M A Blankenstein, G J van Steenbrugge, E Mulder.   

Abstract

Several effects of androgens on LNCaP-FGC prostate tumor cells showed a biphasic pattern. Stimulation of growth and inhibition of secretion of prostatic acid phosphatase (PAP) was observed at low androgen concentrations (below 1 nM of the synthetic androgen R1881), and inhibition of growth and stimulation of PAP secretion was observed at higher concentrations. In contrast, prostate specific antigen (PSA) secretion did not show this biphasic response pattern. Comparable effects were found for two sublines of the LNCaP-FGC cells: an early (passage 20, androgen-dependent) and relatively late (passage 70, androgen-sensitive) passage of the cells. Culturing of both sublines in the presence of a high concentration of androgens (10 nM R1881) resulted initially in a decrease in growth rate, but the cells started to proliferate within 3 weeks. These cells became less sensitive to androgens, lost their biphasic response pattern, and showed reduced androgen receptor levels. Three weeks after removal of the excess of androgens, the passage 70 cells regained a biphasic growth response to androgens. Culture in medium without steroids but with EGF resulted in a decrease of both androgen sensitivity and androgen receptor level. In conclusion, rapid changes of the androgen sensitivity and receptor level of the LNCaP cells occurred under the influence of culture conditions. These changes were partly reversible and, therefore, were most likely due to adaptation of the cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694266     DOI: 10.1002/pros.2990230304

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  21 in total

1.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

2.  Production of milligram concentrations of free prostate specific antigen (fPSA) from LNCaP cell culture: difference between fPSA from LNCaP cell and seminal plasma.

Authors:  J T Wu; B W Lyons; G H Liu; L L Wu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

3.  Transient exposure to androgens induces a remarkable self-sustained quiescent state in dispersed prostate cancer cells.

Authors:  Anh Thu Bui; Meng-Er Huang; Maryline Havard; Fanny Laurent-Tchenio; François Dautry; Thierry Tchenio
Journal:  Cell Cycle       Date:  2017-04-20       Impact factor: 4.534

4.  Best practices for naming, receiving, and managing cells in culture.

Authors:  Yvonne A Reid
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-10-06       Impact factor: 2.416

5.  Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC).

Authors:  John T Isaacs; W Nathaniel Brennen; Samuel R Denmeade
Journal:  Ann Transl Med       Date:  2019-12

6.  Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.

Authors:  Harryl D Martinez; Jordy J Hsiao; Rohini J Jasavala; Izumi V Hinkson; Jimmy K Eng; Michael E Wright
Journal:  Genes Cancer       Date:  2011-10

7.  Supervillin associates with androgen receptor and modulates its transcriptional activity.

Authors:  Huei-Ju Ting; Shuyuan Yeh; Kazuo Nishimura; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

8.  Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancer.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Prostate       Date:  2010-10-01       Impact factor: 4.104

9.  RNA editing of androgen receptor gene transcripts in prostate cancer cells.

Authors:  Harryl D Martinez; Rohini J Jasavala; Izumi Hinkson; Latricia D Fitzgerald; James S Trimmer; Hsing-Jien Kung; Michael E Wright
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

10.  Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.

Authors:  Mikhail G Dozmorov; Robert E Hurst; Daniel J Culkin; Bradley P Kropp; Mark Barton Frank; Jeanette Osban; Trevor M Penning; Hsueh-Kung Lin
Journal:  Prostate       Date:  2009-07-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.